The goal of the Viral Pathogenesis Training Program Is to bring together, under one training program, laboratories at the Fred Hutchinson Cancer Research Center (FHCRC), University of Washington (UW) and the Seattle Biomedical Research Institute (SBRI) to form a unique training opportunity for graduate students pursuing research in viral pathogenesis. Each of these Institutions has a rich history of research in viral pathogenesis, but there are no training programs that are focused specifically on research of viral diseases in the Seattle area. Rather, students interested in viral pathogenesis research can enter one of a variety of UW/FHCRC graduate programs that include virology as one of several focus areas. Trainees for the proposed program will be drawn from the existing graduate programs, and will include all of those who chose to pursue research in viral pathogenesis in the laboratories of faculty who are members of this training program. The training faculty study a variety of relevant research topics including: HIV and other retroviruses, human papillomavirus, HCV, Influenza, and herpesviruses such as CMV and HHV-8. The diversity in the viruses studied among participating labs will add breadth to the program, while maintaining an overarching focus on virus-induced diseases among all the participating labs. This common focus will create an umbrella for the students of this training grant that is distinct from existing departmental or program structures. Features of this training program will include common didactic training as well as opportunities for presentations and other interactions among students and faculty.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Microbiology and Infectious Diseases B Subcommittee (MID)
Program Officer
Robbins, Christiane M
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Washington
Schools of Medicine
United States
Zip Code
Wilson, S S; Tocchi, A; Holly, M K et al. (2015) A small intestinal organoid model of non-invasive enteric pathogen-epithelial cell interactions. Mucosal Immunol 8:352-61
Kell, Alison M; Wargo, Andrew R; Kurath, Gael (2014) Viral fitness does not correlate with three genotype displacement events involving infectious hematopoietic necrosis virus. Virology 464-465:146-55
Gasper, Melanie A; Kunwar, Pratima; Itaya, Grace et al. (2014) Natural killer cell and T-cell subset distributions and activation influence susceptibility to perinatal HIV-1 infection. AIDS 28:1115-24
Omenda, Maxwel M; Milligan, Caitlin; Odem-Davis, Katherine et al. (2013) Evidence for efficient vertical transfer of maternal HIV-1 envelope-specific neutralizing antibodies but no association of such antibodies with reduced infant infection. J Acquir Immune Defic Syndr 64:163-6
Compton, Alex A; Emerman, Michael (2013) Convergence and divergence in the evolution of the APOBEC3G-Vif interaction reveal ancient origins of simian immunodeficiency viruses. PLoS Pathog 9:e1003135
Wilson, Sarah S; Wiens, Mayim E; Smith, Jason G (2013) Antiviral mechanisms of human defensins. J Mol Biol 425:4965-80
Mir, Kiran D; Bosinger, Steven E; Gasper, Melanie et al. (2012) Simian immunodeficiency virus-induced alterations in monocyte production of tumor necrosis factor alpha contribute to reduced immune activation in sooty mangabeys. J Virol 86:7605-15
Compton, Alex A; Hirsch, Vanessa M; Emerman, Michael (2012) The host restriction factor APOBEC3G and retroviral Vif protein coevolve due to ongoing genetic conflict. Cell Host Microbe 11:91-8
Cortez, Valerie; Odem-Davis, Katherine; McClelland, R Scott et al. (2012) HIV-1 superinfection in women broadens and strengthens the neutralizing antibody response. PLoS Pathog 8:e1002611
Provine, Nicholas M; Cortez, Valerie; Chohan, Vrasha et al. (2012) The neutralization sensitivity of viruses representing human immunodeficiency virus type 1 variants of diverse subtypes from early in infection is dependent on producer cell, as well as characteristics of the specific antibody and envelope variant. Virology 427:25-33